Carregant...
Fluconazole resistance in Candida species: a current perspective
Candida albicans and the emerging non-albicans Candida spp. have significant clinical relevance among many patient populations. Current treatment guidelines include fluconazole as a primary therapeutic option for the treatment of these infections, but it is only fungistatic against Candida spp. and...
Guardat en:
| Publicat a: | Infect Drug Resist |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546770/ https://ncbi.nlm.nih.gov/pubmed/28814889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S118892 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|